Results 11 to 20 of about 469,202 (307)

Immunotherapy: Reshape the Tumor Immune Microenvironment

Frontiers in Immunology, 2022
Tumor immune microenvironment (TIME) include tumor cells, immune cells, cytokines, etc. The interactions between these components, which are divided into anti-tumor and pro-tumor, determine the trend of anti-tumor immunity. Although the immune system can
Bingzhe LV, Bingzhe LV, Yunpeng Wang, Yunpeng Wang, Dongjiang Ma, Dongjiang Ma, Wei Cheng, Wei Cheng, Jie Liu, Jie Liu, Tao Yong, Tao Yong, Hao Chen, Hao Chen, Chen Wang, Chen Wang   +15 more
doaj   +3 more sources

Organoid Modeling of the Tumor Immune Microenvironment [PDF]

Cell, 2018
In vitro cancer cultures, including three-dimensional organoids, typically contain exclusively neoplastic epithelium but require artificial reconstitution to recapitulate the tumor microenvironment (TME). The co-culture of primary tumor epithelia with endogenous, syngeneic tumor-infiltrating lymphocytes (TILs) as a cohesive unit has been particularly ...
James T, Neal, Xingnan, Li, Junjie, Zhu, Valeria, Giangarra, Caitlin L, Grzeskowiak, Jihang, Ju, Iris H, Liu, Shin-Heng, Chiou, Ameen A, Salahudeen, Amber R, Smith, Brian C, Deutsch, Lillian, Liao, Allison J, Zemek, Fan, Zhao, Kasper, Karlsson, Liora M, Schultz, Thomas J, Metzner, Lincoln D, Nadauld, Yuen-Yi, Tseng, Sahar, Alkhairy, Coyin, Oh, Paula, Keskula, Daniel, Mendoza-Villanueva, Francisco M, De La Vega, Pamela L, Kunz, Joseph C, Liao, John T, Leppert, John B, Sunwoo, Chiara, Sabatti, Jesse S, Boehm, William C, Hahn, Grace X Y, Zheng, Mark M, Davis, Calvin J, Kuo   +33 more
openaire   +4 more sources

Advantages of targeting the tumor immune microenvironment over blocking immune checkpoint in cancer immunotherapy

Signal Transduction and Targeted Therapy, 2021
Despite great success in cancer immunotherapy, immune checkpoint-targeting drugs are not the most popular weapon in the armory of cancer therapy. Accumulating evidence suggests that the tumor immune microenvironment plays a critical role in anti-cancer ...
Tianyu Tang, Xing Huang, Gang Zhang, Zhengtao Hong, Xueli Bai, Tingbo Liang   +5 more
doaj   +2 more sources

Tumor immune microenvironment lncRNAs [PDF]

Briefings in Bioinformatics, 2021
AbstractLong non-coding ribonucleic acids (RNAs) (lncRNAs) are key players in tumorigenesis and immune responses. The nature of their cell type-specific gene expression and other functional evidence support the idea that lncRNAs have distinct cellular functions in the tumor immune microenvironment (TIME).
Eun-Gyeong Park, Sung-Jin Pyo, Youxi Cui, Sang-Ho Yoon, Jin-Wu Nam   +4 more
openaire   +2 more sources

Vascular Microenvironment, Tumor Immunity and Immunotherapy [PDF]

Frontiers in Immunology, 2021
Immunotherapy holds great promise for treating cancer. Nonetheless, T cell-based immunotherapy of solid tumors has remained challenging, largely due to the lack of universal tumor-specific antigens and an immunosuppressive tumor microenvironment (TME) that inhibits lymphocyte infiltration and activation.
Zachary Lamplugh, Yi Fan
openaire   +3 more sources

Pyroptosis, metabolism, and tumor immune microenvironment [PDF]

Clinical and Translational Medicine, 2021
AbstractIn response to a wide range of stimulations, host cells activate pyroptosis, a kind of inflammatory cell death which is provoked by the cytosolic sensing of danger signals and pathogen infection. In manipulating the cleavage of gasdermins (GSDMs), researchers have found that GSDM proteins serve as the real executors and the deterministic ...
Tiantian Du, Jie Gao, Peilong Li, Yunshan Wang, Qiuchen Qi, Xiaoyan Liu, Juan Li, Chuanxin Wang, Lutao Du   +8 more
openaire   +3 more sources

Chronic stress induces pulmonary epithelial cells to produce acetylcholine that remodels lung pre-metastatic niche of breast cancer by enhancing NETosis

Journal of Experimental & Clinical Cancer Research, 2023
Background Chronic stress promotes most hallmarks of cancer through impacting the malignant tissues, their microenvironment, immunity, lymphatic flow, etc.
Jun Pan, Leyi Zhang, Xiaomei Wang, Lili Li, Chenghui Yang, Zhen Wang, Ke Su, Xiaoxiao Hu, Yi Zhang, Guohong Ren, Jiahuan Jiang, Peng Li, Jian Huang   +12 more
doaj   +1 more source

A comprehensive comparison of circulating tumor cells and breast imaging modalities as screening tools for breast cancer in Chinese women

Frontiers in Oncology, 2022
BackgroundCirculating tumor cells (CTCs) have been recognized as a sensitive biomarker for breast cancer (BC). This study aimed to comprehensively compare CTC with imaging modalities, including ultrasonography, mammography, and contrast-enhanced magnetic
Xuan Shao, Xuan Shao, Xiaoyan Jin, Xiaoyan Jin, Xiaoyan Jin, Zhigang Chen, Zhigang Chen, Zhigang Zhang, Zhigang Zhang, Wuzhen Chen, Wuzhen Chen, Jingxin Jiang, Jingxin Jiang, Zhen Wang, Zhen Wang, Ying Cui, Wan-Hung Fan, Ke Wang, Ke Wang, Xiuyan Yu, Xiuyan Yu, Jian Huang, Jian Huang   +22 more
doaj   +1 more source

Role of Intra- and Extracellular Lipid Signals in Cancer Stemness and Potential Therapeutic Strategy

Frontiers in Pharmacology, 2021
Accumulating evidence showed that cancer stem cells (CSCs) play significant roles in cancer initiation, resistance to therapy, recurrence and metastasis. Cancer stem cells possess the ability of self-renewal and can initiate tumor growth and avoid lethal
Jianming Hu, Jianming Hu, Leyi Zhang, Leyi Zhang, Wuzhen Chen, Wuzhen Chen, Lesang Shen, Lesang Shen, Jingxin Jiang, Jingxin Jiang, Shanshan Sun, Shanshan Sun, Zhigang Chen, Zhigang Chen   +13 more
doaj   +1 more source

Tumor Immune Microenvironment in Gynecologic Cancers

Cancers, 2023
Gynecologic cancers have varying response rates to immunotherapy due to the heterogeneity of each cancer’s molecular biology and features of the tumor immune microenvironment (TIME). This article reviews key features of the TIME and its role in the pathophysiology and treatment of ovarian, endometrial, cervical, vulvar, and vaginal cancer. Knowledge of
Daniel Margul, Camilla Yu, Mariam M. AlHilli   +2 more
openaire   +2 more sources